In this study, we show that endometrial cancer displays the highest mutual exclusivity rate for TP53 and ARID1A mutations, irrespective of histological subtype, across over 10,000 human tumors profiled by The Cancer Genome Atlas (TCGA). The gene discussed is ARID1A; the disease is endometrial cancer.